2012
Karyotype versus Microarray Testing for Genetic Abnormalities after Stillbirth
Reddy UM, Page GP, Saade GR, Silver RM, Thorsten VR, Parker CB, Pinar H, Willinger M, Stoll BJ, Heim-Hall J, Varner MW, Goldenberg RL, Bukowski R, Wapner RJ, Drews-Botsch CD, O'Brien BM, Dudley DJ, Levy B. Karyotype versus Microarray Testing for Genetic Abnormalities after Stillbirth. New England Journal Of Medicine 2012, 367: 2185-2193. PMID: 23215556, PMCID: PMC4295117, DOI: 10.1056/nejmoa1201569.Peer-Reviewed Original ResearchConceptsGenetic abnormalitiesAntepartum stillbirthCongenital anomaliesMicroarray analysisStillbirth Collaborative Research NetworkCopy number variantsAnalysis of stillbirthPopulation-based studyKaryotype analysisResults of karyotypeGeographic catchment areaSingle nucleotide polymorphism arrayClinical significancePostmortem examinationNonviable tissueStillbirthTrue prevalenceFetal tissuesUnaffected personsAbnormalitiesKaryotype resultsMicroarray testingCollaborative research networksGenetic diagnosisPolymorphism array
2009
Delivery Indications at Late-Preterm Gestations and Infant Mortality Rates in the United States
Reddy U, Ko C, Raju T, Willinger M. Delivery Indications at Late-Preterm Gestations and Infant Mortality Rates in the United States. Obstetrical & Gynecological Survey 2009, 64: 780-781. DOI: 10.1097/01.ogx.0000363249.47533.8e.Peer-Reviewed Original ResearchLate preterm birthLate preterm infantsMortality rateInfant mortality rateRecorded indicationDelivery indicationsPreterm birthSpontaneous laborCongenital anomaliesLate preterm gestationLate preterm deliveryMaternal medical conditionsHigher hospitalization ratesMajor congenital anomaliesWeeks of gestationRisk of mortalityPostneonatal mortality ratesNon-Hispanic whitesCategories of indicationsHigher educational levelAbstract InfantsObstetric indicationsPostneonatal morbidityNeonatal dischargeObstetric complications